Antibodies with enhanced antibodydependent cellular cytoxicity activity, methods of their production and use

Details for Australian Patent Application No. 2006304886 (hide)

International Classifications

Event Publications

5 June 2008 PCT application entered the National Phase

PCT publication WO2007/048077 Priority application(s): WO2007/048077

28 April 2011 Alteration of Name

The name of the applicant has been altered to GTC Biotherapeutics, Inc.; Genzyme Corporation Amendments

12 April 2012 Application Accepted

Published as AU-B-2006304886

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.